CLEMENT PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CLEMENT PHARMA
Largest movements
- Receivables within one year -€531,195
down €531,195 (-44.5%), from €1.2m to €663,460
of which Trade receivables: -€554,195
- Cash +€337,432
up €337,432 (+222.6%), from €151,596 to €489,028
mainly Receivables within one year (+€531,195) and Depreciation (+€45,943)
- Tangible fixed assets +€24,906
up €24,906 (+19.9%), from €125,006 to €149,912
of which Furniture and vehicles: +€25,722
- Reserves -€200,000
down €200,000 (-21.9%), from €911,270 to €711,270
of which Distributable reserves: -€200,000
- Profit (loss) carried forward +€39,496
up €39,496 (+82.6%), from €47,821 to €87,317
- Tax, wage and social debts -€31,844
down €31,844 (-8.2%), from €387,308 to €355,465
of which Taxes: -€43,466
- Trade debts +€17,174
up €17,174 (+21.7%), from €79,282 to €96,456
- Staff costs +€127,879
up €127,879 (+12.1%), from €1.1m to €1.2m
- Gross operating margin -€76,541
down €76,541 (-6.5%), from €1.2m to €1.1m
- Taxes -€12,899
down €12,899 (-43.4%), from €29,726 to €16,827
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,487,681 | €1,312,507 | -€175,174 | -11.8% |
| Fixed assets | 21/28 | €125,006 | €149,912 | +€24,906 | +19.9% |
| Tangible fixed assets | 22/27 | €125,006 | €149,912 | +€24,906 | +19.9% |
| Plant, machinery and equipment | 23 | €64 | €0 | -€64 | -100.0% |
| Furniture and vehicles | 24 | €123,786 | €149,508 | +€25,722 | +20.8% |
| Other tangible fixed assets | 26 | €1,157 | €404 | -€753 | -65.1% |
| Current assets | 29/58 | €1,362,675 | €1,162,595 | -€200,080 | -14.7% |
| Amounts receivable within one year | 40/41 | €1,194,656 | €663,460 | -€531,195 | -44.5% |
| Trade receivables | 40 | €1,179,656 | €625,460 | -€554,195 | -47.0% |
| Other amounts receivable | 41 | €15,000 | €38,000 | +€23,000 | +153.3% |
| Cash at bank and in hand | 54/58 | €151,596 | €489,028 | +€337,432 | +222.6% |
| Deferred charges and accrued income | 490/1 | €16,423 | €10,107 | -€6,317 | -38.5% |
| Total equity and liabilities | 10/49 | €1,487,681 | €1,312,507 | -€175,174 | -11.8% |
| Equity | 10/15 | €1,021,091 | €860,587 | -€160,504 | -15.7% |
| Contributions | 10/11 | €62,000 | €62,000 | = | 0.0% |
| Capital | 10 | €62,000 | €62,000 | = | 0.0% |
| Issued capital | 100 | €62,000 | €62,000 | = | 0.0% |
| Reserves | 13 | €911,270 | €711,270 | -€200,000 | -21.9% |
| Non-distributable reserves | 130/1 | €6,200 | €6,200 | = | 0.0% |
| Legal reserve | 130 | €6,200 | €6,200 | = | 0.0% |
| Tax-exempt reserves | 132 | €5,070 | €5,070 | = | 0.0% |
| Distributable reserves | 133 | €900,000 | €700,000 | -€200,000 | -22.2% |
| Profit (loss) carried forward | 14 | €47,821 | €87,317 | +€39,496 | +82.6% |
| Amounts payable | 17/49 | €466,590 | €451,921 | -€14,670 | -3.1% |
| Amounts payable within one year | 42/48 | €466,590 | €451,921 | -€14,670 | -3.1% |
| Trade debts | 44 | €79,282 | €96,456 | +€17,174 | +21.7% |
| Suppliers | 440/4 | €79,282 | €96,456 | +€17,174 | +21.7% |
| Taxes, remuneration and social security | 45 | €387,308 | €355,465 | -€31,844 | -8.2% |
| Taxes | 450/3 | €168,927 | €125,462 | -€43,466 | -25.7% |
| Remuneration and social security | 454/9 | €218,381 | €230,003 | +€11,622 | +5.3% |
| Non-recurring operating income | 76A | €3,735 | €26,656 | +€22,921 | +613.8% |
| Remuneration, social security and pensions | 62 | €1,059,001 | €1,186,880 | +€127,879 | +12.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €36,007 | €45,943 | +€9,936 | +27.6% |
| Other operating charges | 640/8 | €4,442 | €10,800 | +€6,359 | +143.2% |
| Non-recurring operating charges | 66A | €99 | €0 | -€99 | -100.0% |
| Gross operating margin | 9900 | €1,177,040 | €1,100,498 | -€76,541 | -6.5% |
| Operating profit (loss) | 9901 | €77,491 | -€143,125 | -€220,616 | |
| Financial income | 75/76B | €3 | €190 | +€187 | +5462.0% |
| Recurring financial income | 75 | €3 | €190 | +€187 | +5462.0% |
| Financial charges | 65/66B | €440 | €742 | +€302 | +68.5% |
| Recurring financial charges | 65 | €440 | €742 | +€302 | +68.5% |
| Profit (loss) for the period before taxes | 9903 | €77,054 | -€143,677 | -€220,731 | |
| Income taxes | 67/77 | €29,726 | €16,827 | -€12,899 | -43.4% |
| Profit (loss) for the period | 9904 | €47,328 | -€160,504 | -€207,832 | |
| Profit (loss) for the period to be appropriated | 9905 | €47,328 | -€160,504 | -€207,832 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.